Article information
Resumen
El tabaquismo es una enfermedad crónica responsable de una gran variedad de enfermedades, principalmente respiratorias y cardiovasculares. Es sabido que fumar tabaco es el principal factor ambiental vinculado a la patogénesis y al curso de la enfermedad de Crohn (EC); sin embargo, la deshabituación tabáquica, muchas veces no se tiene en cuenta como parte del tratamiento de la enfermedad. En la última década ha habido importantes progresos en cuanto al entendimiento de la fisiopatología y el tratamiento de la adicción tabáquica. En la actualidad se dispone de varios recursos médicos que van desde un breve aviso en la consulta hasta terapias farmacológicas dirigidas a los receptores de nicotina para lograr la deshabituación tabáquica en nuestros pacientes. Es función del gastroenterólogo realizar un consejo médico firme y evaluar la necesidad de tratamientos adyuvantes para lograr que el paciente con EC deje de fumar.
Palabras clave:
Enfermedad de Crohn
Tabaquismo
Deshabituación tabáquica
Nicotina
Abstract
Smoking is a chronic disease that causes a wide variety of health problems, especially respiratory and cardiovascular diseases. Tobacco smoking is the main environmental factor linked to the pathogenesis and clinical course of Crohn's disease. However, smoking cessation is often not included as part of the treatment of this disease. In the last decade, major advances have been made in our understanding of the physiopathology and treatment of nicotine addiction. Several medical resources are currently available, ranging from a brief warning in the consulting room out patient clinic to drug therapies aimed at nicotine receptors to achieve smoking cessation. Gastroenterologists should provide firm medical advice and evaluate the need for adjuvant treatments to achieve smoking cessation in patients with Crohn's disease.
Keywords:
Crohn's disease
Smoking
Smoking cessation
Nicotine
Full text is only aviable in PDF
Bibliografía
[1.]
J. Cosnes.
Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice.
Best Pract Res Clin Gastroenterol, 18 (2004), pp. 481-496
[2.]
T. Birrenbach, U. Böcker.
Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications.
Inflamm Bowel Dis, 10 (2004), pp. 848-859
[3.]
D.K. Hatsukami, L.F. Stead, P.C. Gupta.
Tobacco addiction.
Lancet, 37 (2008), pp. 2027-2038
[4.]
G.A. Giovino.
The tobacco epidemic in the United States.
Am J Prev Med, 33 (2007), pp. S318-S326
[5.]
J. Cornuz.
Smoking cessation interventions in clinical practice.
Eur J Vasc Endovasc Surg, 34 (2007), pp. 397-404
[6.]
N.A. Rigotti.
Clinical practice. Treatment of tobacco use and dependence.
N Engl J Med, 346 (2002), pp. 506-512
[7.]
A.N. Thorndike, N.A. Rigotti, R.S. Stafford, D.E. Singer.
National patterns in the treatment of smokers by physicians.
JAMA, 279 (1998), pp. 604-608
[8.]
U. S. Department of Health and Human Services (USDHHS), The health consequences of smoking: a report of the Surgeon General, USDHHS, Centers for Disease Control and Prevention (CDC), Atlanta GA: National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004
[9.]
A. Ekbom.
The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed?.
Inflamm Bowel Dis, 10 (2004), pp. S32-S34
[10.]
V.E. McGilligan, J.M. Wallace, P.M. Heavey, D.L. Ridley, I.R. Rowland.
Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis.
Inflamm Bowel Dis, 13 (2007), pp. 108-115
[11.]
K.W. Somerville, R.F. Logan, M. Edmond, M.J. Langman.
Smoking and Crohn's disease.
Br Med J, 289 (1984), pp. 954-956
[12.]
S.S. Mahid, K.S. Minor, R.E. Soto, C.A. Hornung, S. Galandiuk.
Smoking and inflammatory bowel disease: a meta-analysis.
Mayo Clin Proc, 81 (2006), pp. 1462-1471
[13.]
E. Lindberg, G. Järnerot, B. Huitfeldt.
Smoking in Crohn's disease: effect on localisation and clinical course.
Gut, 33 (1992), pp. 779-782
[14.]
S.R. Brant, M.F. Picco, J.P. Achkar, T.M. Bayless, S.V. Kane, A. Brzezinski, et al.
Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes.
Inflamm Bowel Dis, 9 (2003), pp. 281-289
[15.]
E. Louis, V. Michel, J.P. Hugot, C. Reenaers, F. Fontaine, M. Delforge, et al.
Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype.
Gut, 52 (2003), pp. 552-557
[16.]
J. Cosnes, F. Carbonnel, F. Carrat, L. Beaugerie, S. Cattan, J. Gendre.
Effects of current and former cigarette smoking on the clinical course of Crohn's disease.
Aliment Pharmacol Ther, 13 (1999), pp. 1403-1411
[17.]
B.D. Breuer-Katschinski, N. Holländer, H. Goebell.
Effect of cigarette smoking on the course of Crohn's disease.
Eur J Gastroenterol Hepatol, 8 (1996), pp. 225-228
[18.]
L.R. Sutherland, S. Ramcharan, H. Bryant, G. Fick.
Effect of cigarette smoking on recurrence of Crohn's disease.
Gastroenterology, 98 (1990), pp. 1123-1128
[19.]
M. Cottone, M. Rosselli, A. Orlando, L. Oliva, A. Puleo, M. Cappello, et al.
Smoking habits and recurrence in Crohn's disease.
Gastroenterology, 106 (1994), pp. 643-648
[20.]
D. Moskovitz, R.S. McLeod, G.R. Greenberg, Z. Cohen.
Operative and environmental risk factors for recurrence of Crohn's disease.
Int J Colorectal Dis, 14 (1999), pp. 224-226
[21.]
T. Yamamoto, M.R. Keighley.
The association of cigarette smoking with a high risk of recurrence after ileocolonic resection for ileocecal Crohn's disease.
Surg Today, 29 (1999), pp. 579-580
[22.]
S.V. Kane, M. Flcker, F. Katz-Nelson.
Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission.
J Clin Gastroenterol, 39 (2005), pp. 32-35
[23.]
J. Cosnes, F. Carbonnel, L. Beaugerie, Y. Le Quintrec, J.P. Gendre.
Effects of cigarette smoking on the long-term course of Crohn's disease.
Gastroenterology, 110 (1996), pp. 424-431
[24.]
M.G. Russel, A. Volovics, E.J. Schoon, E.H. Van Wijlick, R.F. Logan, S. Shivananda, et al.
Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group.
Inflamm Bowel Dis, 4 (1998), pp. 182-186
[25.]
J. Cosnes, L. Beaugerie, F. Carbonnel, J.P. Gendre.
Smoking cessation and the course of Crohn's disease: an intervention study.
Gastroenterology, 120 (2001), pp. 1093-1099
[26.]
P. Seksik, I. Nion-Larmurier, H. Sokol, L. Beaugerie, J. Cosnes.
Effects of light smoking consumption on the clinical course of Crohn's disease.
Inflamm Bowel Dis, (2008),
[27.]
D.T. Jones, M.T. Osterman, M. Bewtra, J.D. Lewis.
Passive smoking and inflammatory bowel disease: a meta-analysis.
Am J Gastroenterol, 103 (2008), pp. 2382-2393
[28.]
F. Van der Heide, A. Dijkstra, R.K. Weersma, F.A. Albersnagel, E.M. Van der Logt, K.N. Faber, et al.
Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis.
Inflamm Bowel Dis, (2009),
[29.]
J. Schmelzle, W.W. Rosser, R. Birtwhistle.
Update on pharmacologic and nonpharmacologic therapies for smoking cessation.
Can Fam Physician, 54 (2008), pp. 994-999
[30.]
L.F. Stead, G. Bergson, T. Lancaster.
Physician advice for smoking cessation.
Cochrane Database Syst Rev, (2008),
[31.]
Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, et al. Treating Tobacco Use and Dependance: Clinical Practice Guideline (revised 2000). Rockville, MD, Agency for Health Care Policy and Research, Public Health Service, US Dept of Health and Human Services, 2000. Disponible en: http://www.ncbi.nih.gov/books/bv.fcgi?rid=hstat2.chapter.7644
[32.]
R. Niaura.
Nonpharmacologic therapy for smoking cessation: characteristics and efficacy of current approaches.
Am J Med, 121 (2008), pp. S11-S19
[33.]
T. Lancaster, L.F. Stead.
Self-help interventions for smoking cessation.
Cochrane Database Syst Rev, (2005),
[34.]
L.F. Stead, T. Lancaster, R. Perera.
Telephone counselling for smoking cessation.
Cochrane Database Syst Rev, (2003),
[35.]
J. Barth, J. Critchley, J. Bengel.
Psychosocial interventions for smoking cessation in patients with coronary heart disease.
Cochrane Database Syst Rev, (2008),
[36.]
A.R. White, H. Rampes, J.L. Campbell.
Acupuncture and related interventions for smoking cessation.
Cochrane Database Syst Rev, (2006),
[37.]
B.H. Marcus, A.E. Albrecht, T.K. King, A.F. Parisi, B.M. Pinto, M. Roberts, et al.
The efficacy of exercise as an aid for smoking cessation in women: a randomized controlled trial.
Arch Intern Med, 159 (1999), pp. 1229-1234
[38.]
L.F. Stead, R. Perera, C. Bullen, D. Mant, T. Lancaster.
Nicotine replacement therapy for smoking cessation.
Cochrane Database Syst Rev, (2008),
[39.]
J.R. Hughes, L.F. Stead, T. Lancaster.
Antidepressants for smoking cessation.
Cochrane Database Syst Rev, (2007),
[40.]
K. Cahill, L.F. Stead, T. Lancaster.
Nicotine receptor partial agonists for smoking cessation.
Cochrane Database Syst Rev, 3 (2008),
[41.]
P. Hajek, L.F. Stead, R. West, M. Jarvis, T. Lancaster.
Relapse prevention interventions for smoking cessation.
Cochrane Database Syst Rev, (2009),
[42.]
J.R. Hughes, E.N. Peters, S. Naud.
Relapse to smoking after 1 year of abstinence: a meta-analysis.
Addict Behav, 33 (2008), pp. 1516-1520
Copyright © 2009. Elsevier España S.L.. Todos los derechos reservados
